id	sid	eid	entity	type
admet-2956	1	1	pd-l1-	GPE
admet-2956	1	2	1	CARDINAL
admet-2956	1	3	admet &	ORG
admet-2956	1	4	13(5	CARDINAL
admet-2956	1	5	2025	CARDINAL
admet-2956	1	6	2956	CARDINAL
admet-2956	1	7	issn	PERSON
admet-2956	1	8	1848-7718	DATE
admet-2956	1	9	pd-l1-	GPE
admet-2956	1	10	adetya rahma dinni2	PERSON
admet-2956	1	11	silvia3	DATE
admet-2956	1	12	laras cantika4	PERSON
admet-2956	1	13	citrawati	ORG
admet-2956	2	1	universitas	ORG
admet-2956	2	2	swadaya gunung jati	PERSON
admet-2956	2	3	cirebon	ORG
admet-2956	2	4	indonesia 2department	EVENT
admet-2956	2	5	universitas	ORG
admet-2956	2	6	swadaya gunung jati	PERSON
admet-2956	2	7	cirebon	ORG
admet-2956	2	8	indonesia 3department	ORG
admet-2956	2	9	gunung jati general hospital	PRODUCT
admet-2956	2	10	cirebon	GPE
admet-2956	2	11	indonesia 4department	ORG
admet-2956	2	12	universitas	ORG
admet-2956	2	13	swadaya gunung jati	PERSON
admet-2956	2	14	cirebon	ORG
admet-2956	2	15	indonesia 5department	ORG
admet-2956	2	16	universitas airlangga	PERSON
admet-2956	2	17	surabaya	GPE
admet-2956	2	18	indonesia	GPE
admet-2956	3	1	july 19, 2025	DATE
admet-2956	3	2	september 26, 2025	DATE
admet-2956	3	3	october 14, 2025	DATE
admet-2956	3	4	pembrolizumab	PERSON
admet-2956	3	5	1	CARDINAL
admet-2956	4	1	pd-l1positive	GPE
admet-2956	5	1	2020	DATE
admet-2956	5	2	six	CARDINAL
admet-2956	5	3	up to march 2025	DATE
admet-2956	8	1	seven	CARDINAL
admet-2956	8	2	4,900	CARDINAL
admet-2956	9	1	pembrolizumab	PERSON
admet-2956	9	2	0.65	CARDINAL
admet-2956	9	3	95 %	PERCENT
admet-2956	9	4	0.57	CARDINAL
admet-2956	9	5	0.73	CARDINAL
admet-2956	9	6	0.00001	CARDINAL
admet-2956	9	7	pfs	PERSON
admet-2956	9	8	0.55	CARDINAL
admet-2956	9	9	95 %	PERCENT
admet-2956	9	10	0.42 to	CARDINAL
admet-2956	9	11	0.72	CARDINAL
admet-2956	9	12	0.0001	CARDINAL
admet-2956	9	13	orr	PERSON
admet-2956	9	14	2.10	CARDINAL
admet-2956	9	15	95 %	PERCENT
admet-2956	9	16	1.51	CARDINAL
admet-2956	9	17	2.93	CARDINAL
admet-2956	9	18	0.0001	CARDINAL
admet-2956	10	1	younger than 65 years	DATE
admet-2956	10	2	0.55	CARDINAL
admet-2956	10	3	65	DATE
admet-2956	10	4	0.72	CARDINAL
admet-2956	10	5	0.44	CARDINAL
admet-2956	10	6	0.67	CARDINAL
admet-2956	11	1	1 %	PERCENT
admet-2956	11	2	0.60	CARDINAL
admet-2956	12	1	pembrolizumab	PERSON
admet-2956	15	1	2025	CARDINAL
admet-2956	17	1	http://creativecommons.org/licenses/by/4.0/ a. chakramurty et al. admet	PERSON
admet-2956	17	2	13(5	CARDINAL
admet-2956	17	3	2025	CARDINAL
admet-2956	17	4	2956 2	CARDINAL
admet-2956	17	5	roughly 85 %	PERCENT
admet-2956	17	6	1,2	CARDINAL
admet-2956	18	1	the past decade	DATE
admet-2956	19	1	3-5	CARDINAL
admet-2956	20	1	6,7	CARDINAL
admet-2956	22	1	10	CARDINAL
admet-2956	24	1	11	CARDINAL
admet-2956	26	1	14,15	CARDINAL
admet-2956	27	1	pembrolizumab	PERSON
admet-2956	27	2	16,17	CARDINAL
admet-2956	28	1	18-20	CARDINAL
admet-2956	29	1	first	ORDINAL
admet-2956	29	2	21,22	CARDINAL
admet-2956	32	1	pd-l1	GPE
admet-2956	33	1	25,26	CARDINAL
admet-2956	34	1	27,28	CARDINAL
admet-2956	35	1	29-31	CARDINAL
admet-2956	37	1	32	CARDINAL
admet-2956	38	1	36	CARDINAL
admet-2956	40	1	41,42	CARDINAL
admet-2956	41	1	pd-l1-	GPE
admet-2956	43	1	secondary	ORDINAL
admet-2956	43	2	13(5	CARDINAL
admet-2956	43	3	2025	CARDINAL
admet-2956	43	4	2956	CARDINAL
admet-2956	43	5	pd-l1-	GPE
admet-2956	43	6	3	CARDINAL
admet-2956	46	1	scopus	ORG
admet-2956	46	2	the cochrane library	ORG
admet-2956	46	3	march 2025	DATE
admet-2956	47	1	boolean operators	ORG
admet-2956	49	1	1	CARDINAL
admet-2956	49	2	pd-l1-	GPE
admet-2956	49	3	2	CARDINAL
admet-2956	49	4	pembrolizumab	PERSON
admet-2956	49	5	3	CARDINAL
admet-2956	49	6	4	CARDINAL
admet-2956	49	7	5	CARDINAL
admet-2956	49	8	english	LANGUAGE
admet-2956	50	1	two	CARDINAL
admet-2956	51	1	third	ORDINAL
admet-2956	53	1	rob 2	PERSON
admet-2956	53	2	five	CARDINAL
admet-2956	54	1	5.4	CARDINAL
admet-2956	55	1	95 %	PERCENT
admet-2956	58	1	1	CARDINAL
admet-2956	59	1	7,459	CARDINAL
admet-2956	59	2	5	CARDINAL
admet-2956	60	1	5,562	CARDINAL
admet-2956	60	2	7	CARDINAL
admet-2956	60	3	between 2016	CARDINAL
admet-2956	60	4	2023	CARDINAL
admet-2956	60	5	1	CARDINAL
admet-2956	61	1	4,900	CARDINAL
admet-2956	61	2	2,084	CARDINAL
admet-2956	61	3	1,816	CARDINAL
admet-2956	62	1	a. chakramurty et	PERSON
admet-2956	62	2	al. admet	ORG
admet-2956	62	3	13(5	CARDINAL
admet-2956	62	4	2025	CARDINAL
admet-2956	62	5	2956 4	DATE
admet-2956	62	6	1	CARDINAL
admet-2956	63	1	prisma	ORG
admet-2956	63	2	1	CARDINAL
admet-2956	66	1	ia l	FAC
admet-2956	67	1	ta l	GPE
admet-2956	67	2	n m	GPE
admet-2956	69	1	n / %	ORG
admet-2956	69	2	n / %	ORG
admet-2956	69	3	n / %	ORG
admet-2956	70	1	asia europe	LOC
admet-2956	70	2	north america	LOC
admet-2956	71	1	0 1	QUANTITY
admet-2956	72	1	2016 010	DATE
admet-2956	72	2	10 mg	QUANTITY
admet-2956	72	3	1,034	CARDINAL
admet-2956	72	4	13.1 634	CARDINAL
admet-2956	72	5	61 %	PERCENT
admet-2956	72	6	399	CARDINAL
admet-2956	72	7	39 %	PERCENT
admet-2956	72	8	222	CARDINAL
admet-2956	72	9	21%	PERCENT
admet-2956	72	10	724	CARDINAL
admet-2956	72	11	70 %	PERCENT
admet-2956	72	12	348	CARDINAL
admet-2956	72	13	34 %	PERCENT
admet-2956	72	14	678	CARDINAL
admet-2956	72	15	66 %	PERCENT
admet-2956	72	16	833	CARDINAL
admet-2956	72	17	81 %	PERCENT
admet-2956	72	18	190	CARDINAL
admet-2956	72	19	18 %	PERCENT
admet-2956	72	20	190	CARDINAL
admet-2956	72	21	18%	PERCENT
admet-2956	72	22	781	CARDINAL
admet-2956	72	23	76 %	PERCENT
admet-2956	72	24	63	DATE
admet-2956	72	25	6 %	PERCENT
admet-2956	73	1	44	CARDINAL
admet-2956	73	2	2016 021 ii	DATE
admet-2956	73	3	123	CARDINAL
admet-2956	73	4	48	DATE
admet-2956	73	5	39 %	PERCENT
admet-2956	73	6	75	DATE
admet-2956	73	7	61 %	PERCENT
admet-2956	73	8	0	CARDINAL
admet-2956	74	1	0%	PERCENT
admet-2956	74	2	121	CARDINAL
admet-2956	74	3	98 %	PERCENT
admet-2956	74	4	53	DATE
admet-2956	74	5	43 %	PERCENT
admet-2956	74	6	69	DATE
admet-2956	74	7	56 %	PERCENT
admet-2956	74	8	99	DATE
admet-2956	74	9	80 %	PERCENT
admet-2956	74	10	24	DATE
admet-2956	74	11	20 %	PERCENT
admet-2956	74	12	0	CARDINAL
admet-2956	75	1	0%	PERCENT
admet-2956	75	2	123	CARDINAL
admet-2956	75	3	100 %	PERCENT
admet-2956	75	4	0	CARDINAL
admet-2956	76	1	0 %	PERCENT
admet-2956	77	1	22	CARDINAL
admet-2956	77	2	2016 024	DATE
admet-2956	77	3	305	CARDINAL
admet-2956	77	4	61 %	PERCENT
admet-2956	77	5	118	CARDINAL
admet-2956	77	6	39 %	PERCENT
admet-2956	77	7	56	DATE
admet-2956	77	8	18 %	PERCENT
admet-2956	77	9	249	CARDINAL
admet-2956	77	10	82 %	PERCENT
admet-2956	77	11	107	CARDINAL
admet-2956	77	12	35 %	PERCENT
admet-2956	77	13	197	CARDINAL
admet-2956	77	14	65 %	PERCENT
admet-2956	77	15	280	CARDINAL
admet-2956	77	16	92 %	PERCENT
admet-2956	77	17	24	DATE
admet-2956	77	18	8 %	PERCENT
admet-2956	77	19	40	DATE
admet-2956	77	20	13 %	PERCENT
admet-2956	77	21	265	CARDINAL
admet-2956	77	22	87 %	PERCENT
admet-2956	77	23	0	CARDINAL
admet-2956	78	1	0 %	PERCENT
admet-2956	79	1	45	CARDINAL
admet-2956	79	2	2019 042 iii	QUANTITY
admet-2956	79	3	1,274	CARDINAL
admet-2956	79	4	12.8 902	CARDINAL
admet-2956	79	5	71 %	PERCENT
admet-2956	79	6	372	CARDINAL
admet-2956	79	7	29 %	PERCENT
admet-2956	79	8	492	CARDINAL
admet-2956	79	9	39 %	PERCENT
admet-2956	79	10	782	CARDINAL
admet-2956	79	11	61 %	PERCENT
admet-2956	79	12	390	CARDINAL
admet-2956	79	13	31 %	PERCENT
admet-2956	79	14	884	CARDINAL
admet-2956	79	15	69 %	PERCENT
admet-2956	79	16	1,041	CARDINAL
admet-2956	79	17	82 %	PERCENT
admet-2956	79	18	282	CARDINAL
admet-2956	79	19	22%	PERCENT
admet-2956	79	20	370	CARDINAL
admet-2956	79	21	29 %	PERCENT
admet-2956	79	22	286	CARDINAL
admet-2956	79	23	22 %	PERCENT
admet-2956	79	24	618	CARDINAL
admet-2956	79	25	49 %	PERCENT
admet-2956	80	1	46	CARDINAL
admet-2956	80	2	2018 407	DATE
admet-2956	80	3	559 7.8 455	MONEY
admet-2956	80	4	81 %	PERCENT
admet-2956	80	5	104	DATE
admet-2956	80	6	19 %	PERCENT
admet-2956	80	7	546	CARDINAL
admet-2956	80	8	98 %	PERCENT
admet-2956	80	9	13	CARDINAL
admet-2956	80	10	2 %	PERCENT
admet-2956	80	11	163	CARDINAL
admet-2956	80	12	29 %	PERCENT
admet-2956	80	13	396	CARDINAL
admet-2956	80	14	71 %	PERCENT
admet-2956	80	15	518	CARDINAL
admet-2956	80	16	93 %	PERCENT
admet-2956	80	17	41	CARDINAL
admet-2956	80	18	7%	PERCENT
admet-2956	80	19	106	CARDINAL
admet-2956	80	20	19 %	PERCENT
admet-2956	80	21	453	CARDINAL
admet-2956	80	22	81 %	PERCENT
admet-2956	80	23	0	CARDINAL
admet-2956	81	1	0 %	PERCENT
admet-2956	82	1	47	CARDINAL
admet-2956	82	2	2023 033	CARDINAL
admet-2956	82	3	425	CARDINAL
admet-2956	82	4	321	CARDINAL
admet-2956	82	5	76 %	PERCENT
admet-2956	82	6	104	DATE
admet-2956	82	7	24 %	PERCENT
admet-2956	82	8	170	CARDINAL
admet-2956	82	9	40 %	PERCENT
admet-2956	82	10	247	CARDINAL
admet-2956	82	11	58 %	PERCENT
admet-2956	82	12	6 9	DATE
admet-2956	82	13	16 %	PERCENT
admet-2956	82	14	356	CARDINAL
admet-2956	82	15	84 %	PERCENT
admet-2956	82	16	354	CARDINAL
admet-2956	82	17	83 %	PERCENT
admet-2956	82	18	71	DATE
admet-2956	82	19	17%	PERCENT
admet-2956	82	20	358	CARDINAL
admet-2956	82	21	84 %	PERCENT
admet-2956	82	22	67	DATE
admet-2956	82	23	16 %	PERCENT
admet-2956	82	24	0	CARDINAL
admet-2956	83	1	0 %	PERCENT
admet-2956	84	1	48	CARDINAL
admet-2956	84	2	2018 189	DATE
admet-2956	84	3	616	CARDINAL
admet-2956	84	4	10.5 363	CARDINAL
admet-2956	84	5	59 %	PERCENT
admet-2956	84	6	253	CARDINAL
admet-2956	84	7	4 1%	PERCENT
admet-2956	84	8	0	CARDINAL
admet-2956	85	1	0 %	PERCENT
admet-2956	85	2	606	CARDINAL
admet-2956	85	3	98 %	PERCENT
admet-2956	85	4	266	CARDINAL
admet-2956	85	5	43 %	PERCENT
admet-2956	85	6	346	CARDINAL
admet-2956	85	7	56 %	PERCENT
admet-2956	85	8	543	CARDINAL
admet-2956	85	9	88 %	PERCENT
admet-2956	85	10	73	DATE
admet-2956	85	11	12%	PERCENT
admet-2956	85	12	10	CARDINAL
admet-2956	85	13	2 %	PERCENT
admet-2956	85	14	531	CARDINAL
admet-2956	85	15	86 %	PERCENT
admet-2956	85	16	75	DATE
admet-2956	85	17	12 %	PERCENT
admet-2956	85	18	one	CARDINAL
admet-2956	86	1	2	CARDINAL
admet-2956	86	2	5	CARDINAL
admet-2956	86	3	2	CARDINAL
admet-2956	88	1	2	CARDINAL
admet-2956	88	2	1	CARDINAL
admet-2956	88	3	2	CARDINAL
admet-2956	88	4	20.3 to 66 %	PERCENT
admet-2956	88	5	3	CARDINAL
admet-2956	89	1	13(5	CARDINAL
admet-2956	89	2	2025	CARDINAL
admet-2956	89	3	2956	CARDINAL
admet-2956	89	4	pd-l1-	GPE
admet-2956	89	5	5	CARDINAL
admet-2956	89	6	2	CARDINAL
admet-2956	89	7	5	CARDINAL
admet-2956	91	1	seven	CARDINAL
admet-2956	92	1	pembrolizumab	PERSON
admet-2956	92	2	2.10	CARDINAL
admet-2956	92	3	95 %	PERCENT
admet-2956	92	4	1.51-2.93	CARDINAL
admet-2956	92	5	0.0001	CARDINAL
admet-2956	92	6	404	CARDINAL
admet-2956	92	7	931	CARDINAL
admet-2956	92	8	209	CARDINAL
admet-2956	92	9	876	CARDINAL
admet-2956	92	10	3a	CARDINAL
admet-2956	93	1	78 %	PERCENT
admet-2956	93	2	0.0001	CARDINAL
admet-2956	94	1	six	CARDINAL
admet-2956	94	2	the pd-l1-positive group	ORG
admet-2956	95	1	pembrolizumab	PERSON
admet-2956	95	2	35 %	PERCENT
admet-2956	95	3	0.65	CARDINAL
admet-2956	95	4	95 %	PERCENT
admet-2956	95	5	0.57-0.73	CARDINAL
admet-2956	95	6	3b	CARDINAL
admet-2956	96	1	30 %	PERCENT
admet-2956	96	2	0.21	CARDINAL
admet-2956	98	1	six	CARDINAL
admet-2956	98	2	45 %	PERCENT
admet-2956	98	3	0.55	CARDINAL
admet-2956	98	4	95 %	PERCENT
admet-2956	98	5	0.42-0.72	CARDINAL
admet-2956	98	6	0.0001	CARDINAL
admet-2956	98	7	3c	CARDINAL
admet-2956	99	1	81 %	PERCENT
admet-2956	99	2	0.00001	CARDINAL
admet-2956	101	1	a. chakramurty et	PERSON
admet-2956	101	2	al. admet	ORG
admet-2956	101	3	13(5	CARDINAL
admet-2956	101	4	2025	CARDINAL
admet-2956	101	5	2956 6	CARDINAL
admet-2956	101	6	3	CARDINAL
admet-2956	101	7	4,168	CARDINAL
admet-2956	101	8	3,632	CARDINAL
admet-2956	101	9	seven	CARDINAL
admet-2956	102	1	pembrolizumab	PERSON
admet-2956	102	2	2	CARDINAL
admet-2956	103	1	3-5	CARDINAL
admet-2956	103	2	11.3	CARDINAL
admet-2956	103	3	67.2 %	PERCENT
admet-2956	103	4	25.8	CARDINAL
admet-2956	103	5	68.2 %	PERCENT
admet-2956	103	6	2	CARDINAL
admet-2956	103	7	4.4%	PERCENT
admet-2956	103	8	13.6%	PERCENT
admet-2956	103	9	6.4 to 12.7 %	PERCENT
admet-2956	104	1	•	CARDINAL
admet-2956	104	2	0.9 to 6.6 %	PERCENT
admet-2956	104	3	•	CARDINAL
admet-2956	104	4	1.5 to 13.1 %	PERCENT
admet-2956	104	5	•	CARDINAL
admet-2956	105	1	13(5	CARDINAL
admet-2956	105	2	2025	CARDINAL
admet-2956	105	3	2956	CARDINAL
admet-2956	105	4	pd-l1-	GPE
admet-2956	105	5	7	CARDINAL
admet-2956	105	6	2	CARDINAL
admet-2956	106	1	aes	ORG
admet-2956	106	2	3	CARDINAL
admet-2956	106	3	aes	ORG
admet-2956	106	4	n / %	ORG
admet-2956	106	5	n / %	ORG
admet-2956	106	6	aes	ORG
admet-2956	107	1	43	CARDINAL
admet-2956	107	2	344	CARDINAL
admet-2956	107	3	215/339	TIME
admet-2956	107	4	63.4 %	PERCENT
admet-2956	107	5	43/339	DATE
admet-2956	107	6	12.7 %	PERCENT
admet-2956	107	7	3/344	CARDINAL
admet-2956	107	8	0.9 %	PERCENT
admet-2956	107	9	15/344	DATE
admet-2956	107	10	4.4 %	PERCENT
admet-2956	107	11	343 251/309	QUANTITY
admet-2956	107	12	81.2 %	PERCENT
admet-2956	108	1	109/309	DATE
admet-2956	108	2	35.3 %	PERCENT
admet-2956	108	3	5/343	DATE
admet-2956	108	4	1.5 %	PERCENT
admet-2956	108	5	31/343	DATE
admet-2956	108	6	9.0 %	PERCENT
admet-2956	109	1	44	CARDINAL
admet-2956	109	2	60 55/59	CARDINAL
admet-2956	109	3	93.2 %	PERCENT
admet-2956	110	1	23/59	CARDINAL
admet-2956	110	2	39.0 %	PERCENT
admet-2956	110	3	1/60	CARDINAL
admet-2956	110	4	1.7 %	PERCENT
admet-2956	110	5	6/60	CARDINAL
admet-2956	110	6	10.0 %	PERCENT
admet-2956	110	7	63 56/62	CARDINAL
admet-2956	110	8	90.3 %	PERCENT
admet-2956	111	1	16/62	CARDINAL
admet-2956	111	2	25.8 %	PERCENT
admet-2956	111	3	2/63	CARDINAL
admet-2956	111	4	3.2 %	PERCENT
admet-2956	111	5	8/63	CARDINAL
admet-2956	111	6	12.7 %	PERCENT
admet-2956	112	1	22	CARDINAL
admet-2956	112	2	154 118/154	DATE
admet-2956	112	3	76.6 %	PERCENT
admet-2956	112	4	48/154	CARDINAL
admet-2956	112	5	31.2 %	PERCENT
admet-2956	112	6	2/154	CARDINAL
admet-2956	112	7	1.3 %	PERCENT
admet-2956	112	8	21/154	CARDINAL
admet-2956	112	9	13.6 %	PERCENT
admet-2956	112	10	151 135/150	QUANTITY
admet-2956	112	11	90.0 %	PERCENT
admet-2956	112	12	80/150	CARDINAL
admet-2956	113	1	53.3 %	PERCENT
admet-2956	113	2	3/151	CARDINAL
admet-2956	113	3	16/151	DATE
admet-2956	113	4	10.6 %	PERCENT
admet-2956	114	1	45	CARDINAL
admet-2956	114	2	62.7 %	PERCENT
admet-2956	115	1	17.8 %	PERCENT
admet-2956	115	2	13/637	CARDINAL
admet-2956	115	3	2.0 %	PERCENT
admet-2956	115	4	57/637	DATE
admet-2956	115	5	8.9 %	PERCENT
admet-2956	115	6	637 553/615	CARDINAL
admet-2956	115	7	89.9 %	PERCENT
admet-2956	116	1	41.0 %	PERCENT
admet-2956	116	2	14/637	DATE
admet-2956	116	3	2.2 %	PERCENT
admet-2956	117	1	58/637	DATE
admet-2956	117	2	9.1 %	PERCENT
admet-2956	118	1	46	CARDINAL
admet-2956	118	2	278 273/278	QUANTITY
admet-2956	118	3	98.2 %	PERCENT
admet-2956	119	1	194/278	DATE
admet-2956	119	2	69.8 %	PERCENT
admet-2956	119	3	10/278	CARDINAL
admet-2956	119	4	3.6 %	PERCENT
admet-2956	119	5	37/278	CARDINAL
admet-2956	119	6	13.3 %	PERCENT
admet-2956	119	7	281 274/280	CARDINAL
admet-2956	119	8	97.9 %	PERCENT
admet-2956	119	9	191/280	CARDINAL
admet-2956	119	10	68.2 %	PERCENT
admet-2956	119	11	6/281	CARDINAL
admet-2956	119	12	2.1 %	PERCENT
admet-2956	119	13	18/281	CARDINAL
admet-2956	119	14	6.4 %	PERCENT
admet-2956	120	1	47	CARDINAL
admet-2956	120	2	213 149/213	CARDINAL
admet-2956	120	3	70.0 %	PERCENT
admet-2956	120	4	24/213	CARDINAL
admet-2956	120	5	11.3 %	PERCENT
admet-2956	120	6	4/213	CARDINAL
admet-2956	120	7	1.9 %	PERCENT
admet-2956	120	8	21/213	CARDINAL
admet-2956	120	9	9.9 %	PERCENT
admet-2956	120	10	212 174/198	DATE
admet-2956	120	11	87.9 %	PERCENT
admet-2956	121	1	94/198	CARDINAL
admet-2956	121	2	47.5 %	PERCENT
admet-2956	121	3	4/212	CARDINAL
admet-2956	121	4	1.9 %	PERCENT
admet-2956	121	5	7.1 %	PERCENT
admet-2956	122	1	48	CARDINAL
admet-2956	122	2	410	CARDINAL
admet-2956	122	3	404/405	MONEY
admet-2956	122	4	99.8 %	PERCENT
admet-2956	123	1	272/405	DATE
admet-2956	123	2	67.2 %	PERCENT
admet-2956	123	3	27/410	CARDINAL
admet-2956	123	4	6.6 %	PERCENT
admet-2956	123	5	206	CARDINAL
admet-2956	123	6	200/202	ORG
admet-2956	123	7	99.0 %	PERCENT
admet-2956	123	8	133/202	DATE
admet-2956	123	9	65.8 %	PERCENT
admet-2956	123	10	27/206	DATE
admet-2956	123	11	13.1 %	PERCENT
admet-2956	123	12	20.1	CARDINAL
admet-2956	123	13	34.4 %	PERCENT
admet-2956	123	14	5.3 to 11.3 %	PERCENT
admet-2956	124	1	3-5	CARDINAL
admet-2956	124	2	5.1 to 13.6 %	PERCENT
admet-2956	124	3	0.7 to 3.2 %	PERCENT
admet-2956	125	1	3	CARDINAL
admet-2956	125	2	4.0 to 9.9 %	PERCENT
admet-2956	125	3	0 to 2.5 %	PERCENT
admet-2956	125	4	3-5	CARDINAL
admet-2956	125	5	1.7 to 3.2 %	PERCENT
admet-2956	125	6	0 to 2.0 %	PERCENT
admet-2956	126	1	7.9 to 15.3 %	PERCENT
admet-2956	126	2	0.3	CARDINAL
admet-2956	126	3	11.9 %	PERCENT
admet-2956	126	4	3-5	CARDINAL
admet-2956	126	5	0 to 1.0 %	PERCENT
admet-2956	126	6	0 to 0.5 %	PERCENT
admet-2956	126	7	4.0 to 8.0 %	PERCENT
admet-2956	126	8	0	CARDINAL
admet-2956	126	9	3.0 %	PERCENT
admet-2956	127	1	3	CARDINAL
admet-2956	128	1	iraes	NORP
admet-2956	128	2	n / %	ORG
admet-2956	128	3	3	CARDINAL
admet-2956	128	4	n / %	ORG
admet-2956	129	1	43	CARDINAL
admet-2956	129	2	2	CARDINAL
admet-2956	129	3	344 69/344	CARDINAL
admet-2956	129	4	20.1 %	PERCENT
admet-2956	130	1	8 %	PERCENT
admet-2956	130	2	4 %	PERCENT
admet-2956	130	3	4 %	PERCENT
admet-2956	130	4	343	CARDINAL
admet-2956	130	5	44	CARDINAL
admet-2956	130	6	60 13/59	CARDINAL
admet-2956	130	7	22.0 %	PERCENT
admet-2956	131	1	3/59	DATE
admet-2956	131	2	5.1 %	PERCENT
admet-2956	131	3	15 %	PERCENT
admet-2956	131	4	8 %	PERCENT
admet-2956	131	5	5 %	PERCENT
admet-2956	131	6	63 7/62	DATE
admet-2956	131	7	11.3 %	PERCENT
admet-2956	131	8	0/62	DATE
admet-2956	132	1	0 %	PERCENT
admet-2956	132	2	22	CARDINAL
admet-2956	132	3	154 53/154	CARDINAL
admet-2956	132	4	34.4 %	PERCENT
admet-2956	132	5	21/154	CARDINAL
admet-2956	132	6	13.6 %	PERCENT
admet-2956	132	7	10.4 %	PERCENT
admet-2956	132	8	7.1 %	PERCENT
admet-2956	132	9	8.4 %	PERCENT
admet-2956	132	10	151 8/150	PERCENT
admet-2956	132	11	5.3 %	PERCENT
admet-2956	132	12	1/150	CARDINAL
admet-2956	132	13	0.7 %	PERCENT
admet-2956	132	14	45	CARDINAL
admet-2956	132	15	637 177/636	DATE
admet-2956	132	16	27.8 %	PERCENT
admet-2956	132	17	51/636	CARDINAL
admet-2956	132	18	8.0 %	PERCENT
admet-2956	132	19	22	CARDINAL
admet-2956	132	20	11	CARDINAL
admet-2956	132	21	7	CARDINAL
admet-2956	132	22	637 44/615	CARDINAL
admet-2956	132	23	7.2 %	PERCENT
admet-2956	132	24	9/615	CARDINAL
admet-2956	132	25	1.5 %	PERCENT
admet-2956	132	26	46	CARDINAL
admet-2956	132	27	278	CARDINAL
admet-2956	132	28	28.8 %	PERCENT
admet-2956	132	29	30/278	DATE
admet-2956	132	30	10.8 %	PERCENT
admet-2956	132	31	7.9 %	PERCENT
admet-2956	132	32	6.5 %	PERCENT
admet-2956	132	33	2.5 %	PERCENT
admet-2956	132	34	281 24/280	CARDINAL
admet-2956	132	35	8.6 %	PERCENT
admet-2956	132	36	9/280	DATE
admet-2956	132	37	3.2 %	PERCENT
admet-2956	132	38	47	CARDINAL
admet-2956	132	39	213 61/213	CARDINAL
admet-2956	132	40	28.6 %	PERCENT
admet-2956	132	41	13/213	CARDINAL
admet-2956	132	42	6.1 %	PERCENT
admet-2956	132	43	13.1 %	PERCENT
admet-2956	132	44	9.9 %	PERCENT
admet-2956	132	45	1.9 %	PERCENT
admet-2956	132	46	212 12/198	CARDINAL
admet-2956	132	47	6.1 %	PERCENT
admet-2956	132	48	3/198	DATE
admet-2956	132	49	1.5 %	PERCENT
admet-2956	132	50	48	CARDINAL
admet-2956	132	51	410	CARDINAL
admet-2956	132	52	206	CARDINAL
admet-2956	132	53	a. chakramurty et	PERSON
admet-2956	132	54	al. admet	ORG
admet-2956	132	55	13(5	CARDINAL
admet-2956	132	56	2025	CARDINAL
admet-2956	132	57	2956 8	DATE
admet-2956	132	58	0 to 38 %	PERCENT
admet-2956	132	59	6 to 24 %	PERCENT
admet-2956	132	60	3-5	CARDINAL
admet-2956	132	61	0 to 23 %	PERCENT
admet-2956	132	62	2 to 25 %	PERCENT
admet-2956	133	1	1 to 56 %	PERCENT
admet-2956	133	2	13 to 52 %	PERCENT
admet-2956	133	3	2 to 31 %	PERCENT
admet-2956	133	4	7 to 23 %	PERCENT
admet-2956	133	5	0.6 to 3.9 %	PERCENT
admet-2956	133	6	0 % to 1.4 %	PERCENT
admet-2956	134	1	pembrolizumab	PERSON
admet-2956	136	1	pfs	PERSON
admet-2956	136	2	4 and 5	DATE
admet-2956	137	1	younger than 65 years	DATE
admet-2956	137	2	0.55	CARDINAL
admet-2956	137	3	95 %	PERCENT
admet-2956	137	4	0.46	CARDINAL
admet-2956	137	5	0.65	CARDINAL
admet-2956	137	6	65 years or older	DATE
admet-2956	137	7	0.72	CARDINAL
admet-2956	137	8	95 %	PERCENT
admet-2956	137	9	0.59	CARDINAL
admet-2956	137	10	0.88	CARDINAL
admet-2956	137	11	0.001	CARDINAL
admet-2956	138	1	0.46	CARDINAL
admet-2956	138	2	95 %	PERCENT
admet-2956	138	3	0.38-0.57	CARDINAL
admet-2956	138	4	0.00001	CARDINAL
admet-2956	138	5	0.68	CARDINAL
admet-2956	138	6	95 %	PERCENT
admet-2956	138	7	0.55 to 0.85	CARDINAL
admet-2956	138	8	0.0005	CARDINAL
admet-2956	139	1	zero	CARDINAL
admet-2956	139	2	i²=0 %	PERCENT
admet-2956	139	3	i²=0 %	PERCENT
admet-2956	141	1	the pd-l1 ≥50 %	FAC
admet-2956	141	2	0.44	CARDINAL
admet-2956	141	3	95 %	PERCENT
admet-2956	141	4	0.24-0.82	CARDINAL
admet-2956	141	5	0.67	CARDINAL
admet-2956	141	6	95 %	PERCENT
admet-2956	141	7	0.57-0.79	CARDINAL
admet-2956	143	1	0.43	CARDINAL
admet-2956	143	2	95 %	PERCENT
admet-2956	143	3	0.32-0.56	CARDINAL
admet-2956	143	4	0.61	CARDINAL
admet-2956	143	5	95 %	PERCENT
admet-2956	143	6	0.51-0.73	CARDINAL
admet-2956	143	7	2	CARDINAL
admet-2956	144	1	i²=0 %	PERCENT
admet-2956	146	1	0	CARDINAL
admet-2956	147	1	0.60	CARDINAL
admet-2956	147	2	95 %	PERCENT
admet-2956	147	3	0.47	CARDINAL
admet-2956	147	4	0.77	CARDINAL
admet-2956	147	5	1	CARDINAL
admet-2956	147	6	0.66	CARDINAL
admet-2956	147	7	95 %	PERCENT
admet-2956	147	8	0.57	CARDINAL
admet-2956	147	9	0.00001	CARDINAL
admet-2956	148	1	0	CARDINAL
admet-2956	148	2	38 %	PERCENT
admet-2956	148	3	1	CARDINAL
admet-2956	148	4	0 %	PERCENT
admet-2956	149	1	pfs	PERSON
admet-2956	149	2	0	CARDINAL
admet-2956	149	3	0.47	CARDINAL
admet-2956	149	4	95 %	PERCENT
admet-2956	149	5	0.36	CARDINAL
admet-2956	149	6	0.62	CARDINAL
admet-2956	149	7	1	CARDINAL
admet-2956	149	8	0.59	CARDINAL
admet-2956	149	9	95 %	PERCENT
admet-2956	149	10	0.49	CARDINAL
admet-2956	149	11	0.70	CARDINAL
admet-2956	149	12	2	CARDINAL
admet-2956	150	1	13(5	CARDINAL
admet-2956	150	2	2025	CARDINAL
admet-2956	150	3	2956	CARDINAL
admet-2956	150	4	pd-l1-	GPE
admet-2956	150	5	9	CARDINAL
admet-2956	150	6	0 %	PERCENT
admet-2956	152	1	4 and 5	DATE
admet-2956	152	2	less than 1 %	PERCENT
admet-2956	152	3	0.60	CARDINAL
admet-2956	152	4	95 %	PERCENT
admet-2956	152	5	0.43	CARDINAL
admet-2956	152	6	0.83	CARDINAL
admet-2956	152	7	0.002	CARDINAL
admet-2956	153	1	1 to 49 %	PERCENT
admet-2956	153	2	0.56	CARDINAL
admet-2956	153	3	95 %	PERCENT
admet-2956	153	4	0.40	CARDINAL
admet-2956	153	5	0.78	CARDINAL
admet-2956	153	6	p=0.0006	DATE
admet-2956	154	1	4	CARDINAL
admet-2956	155	1	95 %	PERCENT
admet-2956	156	1	age < 65 years	DATE
admet-2956	156	2	3 0.55 0.46-0.65 44	QUANTITY
admet-2956	156	3	0.00001	CARDINAL
admet-2956	156	4	age ≥ 65 years	DATE
admet-2956	156	5	3 0.72 0.59-0.88	QUANTITY
admet-2956	156	6	0.001	CARDINAL
admet-2956	156	7	3 0.67 0.57-0.79	QUANTITY
admet-2956	156	8	3 0.44 0.24-0.82 87	QUANTITY
admet-2956	156	9	0.009	CARDINAL
admet-2956	156	10	0	CARDINAL
admet-2956	156	11	3 0.60 0.47-0.77 38	QUANTITY
admet-2956	156	12	0.0001	CARDINAL
admet-2956	156	13	1	CARDINAL
admet-2956	156	14	3 0.66 0.57-0.77	QUANTITY
admet-2956	156	15	0.00001	CARDINAL
admet-2956	156	16	pd-l1 tps	GPE
admet-2956	156	17	1 %	PERCENT
admet-2956	156	18	2 0.60 0.43-0.83	QUANTITY
admet-2956	156	19	0.002	CARDINAL
admet-2956	156	20	pd-l1 tps	GPE
admet-2956	156	21	1 %	PERCENT
admet-2956	156	22	5 0.71 0.60-0.84 59	QUANTITY
admet-2956	156	23	0.0001	CARDINAL
admet-2956	156	24	pd-l1	GPE
admet-2956	156	25	1-49 %	PERCENT
admet-2956	156	26	2 0.56 0.40-0.78	QUANTITY
admet-2956	156	27	0.0006	CARDINAL
admet-2956	156	28	1 %	PERCENT
admet-2956	156	29	0.71	CARDINAL
admet-2956	156	30	95 %	PERCENT
admet-2956	156	31	0.60	CARDINAL
admet-2956	156	32	0.84	CARDINAL
admet-2956	156	33	0.0001	CARDINAL
admet-2956	157	1	less than 1 %	PERCENT
admet-2956	157	2	0.60	CARDINAL
admet-2956	157	3	95 %	PERCENT
admet-2956	157	4	0.43	CARDINAL
admet-2956	157	5	0.83	CARDINAL
admet-2956	157	6	0.002	CARDINAL
admet-2956	158	1	tps	ORG
admet-2956	158	2	between 1 and	CARDINAL
admet-2956	158	3	49 %	PERCENT
admet-2956	158	4	0.56	CARDINAL
admet-2956	158	5	95 %	PERCENT
admet-2956	158	6	0.43-0.73	CARDINAL
admet-2956	158	7	0.0001	CARDINAL
admet-2956	159	1	5	CARDINAL
admet-2956	160	1	95 %	PERCENT
admet-2956	161	1	age < 65 years	DATE
admet-2956	161	2	2 0.46 0.38-0.57	QUANTITY
admet-2956	161	3	0.00001	CARDINAL
admet-2956	161	4	age ≥ 65 years	DATE
admet-2956	161	5	2 0.68 0.55-0.85	QUANTITY
admet-2956	162	1	0.0005	CARDINAL
admet-2956	162	2	2 0.61 0.51-0.73	QUANTITY
admet-2956	162	3	0.00001	CARDINAL
admet-2956	162	4	2 0.43 0.32-0.56	QUANTITY
admet-2956	162	5	0.00001	CARDINAL
admet-2956	162	6	0	CARDINAL
admet-2956	162	7	2 0.47 0.36-0.62 0	QUANTITY
admet-2956	162	8	0.00001	CARDINAL
admet-2956	162	9	1	CARDINAL
admet-2956	162	10	2 0.59 0.49-0.70	QUANTITY
admet-2956	162	11	0.00001	CARDINAL
admet-2956	162	12	pd-l1 tps	GPE
admet-2956	162	13	1 %	PERCENT
admet-2956	162	14	2 0.60 0.43-0.83 %	QUANTITY
admet-2956	162	15	0.002	CARDINAL
admet-2956	162	16	1 %	PERCENT
admet-2956	162	17	5 0.74 0.54-1.01 90	QUANTITY
admet-2956	162	18	pd-l1	GPE
admet-2956	162	19	1-49 %	PERCENT
admet-2956	162	20	2 0.56 0.43-0.73	QUANTITY
admet-2956	163	1	0.0001	CARDINAL
admet-2956	163	2	1 %	PERCENT
admet-2956	163	3	0.74	CARDINAL
admet-2956	163	4	95 %	PERCENT
admet-2956	163	5	0.54	CARDINAL
admet-2956	163	6	1.01	CARDINAL
admet-2956	163	7	0.05	CARDINAL
admet-2956	165	1	a. chakramurty et	PERSON
admet-2956	165	2	al. admet	ORG
admet-2956	165	3	13(5	CARDINAL
admet-2956	165	4	2025	CARDINAL
admet-2956	165	5	2956 10	DATE
admet-2956	165	6	tps	ORG
admet-2956	165	7	1 %	PERCENT
admet-2956	169	1	4	CARDINAL
admet-2956	171	1	4	CARDINAL
admet-2956	172	1	pembrolizumab	PERSON
admet-2956	173	1	45 %	PERCENT
admet-2956	173	2	pembrolizumab	PERSON
admet-2956	173	3	0.55	CARDINAL
admet-2956	173	4	95 %	PERCENT
admet-2956	173	5	0.42-0.72	CARDINAL
admet-2956	174	1	keynote-024	ORG
admet-2956	174	2	0.50	CARDINAL
admet-2956	174	3	95 %	PERCENT
admet-2956	174	4	0.37 to 0.68	CARDINAL
admet-2956	174	5	keynote-042	ORG
admet-2956	174	6	0.81	CARDINAL
admet-2956	174	7	95 %	PERCENT
admet-2956	174	8	0.71 to 0.93	CARDINAL
admet-2956	175	1	46	CARDINAL
admet-2956	176	1	2.10	CARDINAL
admet-2956	176	2	95 %	PERCENT
admet-2956	176	3	1.51 to	CARDINAL
admet-2956	176	4	2.93	CARDINAL
admet-2956	177	1	49	CARDINAL
admet-2956	178	1	one	CARDINAL
admet-2956	179	1	below 1%	PERCENT
admet-2956	179	2	0.60	CARDINAL
admet-2956	179	3	95%	PERCENT
admet-2956	179	4	0.43 to 0.83	CARDINAL
admet-2956	179	5	50	CARDINAL
admet-2956	180	1	13(5	CARDINAL
admet-2956	180	2	2025	CARDINAL
admet-2956	180	3	2956	CARDINAL
admet-2956	180	4	pd-l1-	GPE
admet-2956	180	5	11	CARDINAL
admet-2956	180	6	fda	ORG
admet-2956	180	7	51	CARDINAL
admet-2956	181	1	52	CARDINAL
admet-2956	183	1	65 years	DATE
admet-2956	183	2	0.55	CARDINAL
admet-2956	183	3	0.72	CARDINAL
admet-2956	184	1	53	CARDINAL
admet-2956	185	1	0.44	CARDINAL
admet-2956	185	2	0.67	CARDINAL
admet-2956	185	3	54	CARDINAL
admet-2956	188	1	up to 30 to 40 %	DATE
admet-2956	188	2	55	CARDINAL
admet-2956	189	1	this pd-l1	ORG
admet-2956	189	2	56	CARDINAL
admet-2956	191	1	57	CARDINAL
admet-2956	194	1	58	CARDINAL
admet-2956	194	2	59	CARDINAL
admet-2956	195	1	60	CARDINAL
admet-2956	198	1	pembrolizumab	PERSON
admet-2956	198	2	4 to 9.9 %	PERCENT
admet-2956	198	3	7.9 to 15.3 %	PERCENT
admet-2956	199	1	0 to 23 %	PERCENT
admet-2956	199	2	2 to 25 %	PERCENT
admet-2956	200	1	61	CARDINAL
admet-2956	202	1	pd-l1 assays	GPE
admet-2956	203	1	62	CARDINAL
admet-2956	205	1	asian	NORP
admet-2956	205	2	63	CARDINAL
admet-2956	207	1	64	CARDINAL
admet-2956	208	1	65	CARDINAL
admet-2956	209	1	66	CARDINAL
admet-2956	210	1	a. chakramurty et	PERSON
admet-2956	210	2	al. admet	ORG
admet-2956	210	3	13(5	CARDINAL
admet-2956	210	4	2025	CARDINAL
admet-2956	210	5	2956 12	CARDINAL
admet-2956	210	6	67	CARDINAL
admet-2956	211	1	68	CARDINAL
admet-2956	213	1	69	CARDINAL
admet-2956	214	1	70	CARDINAL
admet-2956	228	1	1	CARDINAL
admet-2956	228	2	n. duma	PERSON
admet-2956	228	3	r. santana-davila	PERSON
admet-2956	228	4	j.r. molina	PERSON
admet-2956	230	1	94	CARDINAL
admet-2956	230	2	2019	DATE
admet-2956	231	1	2	CARDINAL
admet-2956	231	2	s. singhal	PERSON
admet-2956	231	3	p. kulkarni	PERSON
admet-2956	231	4	d. horne	PERSON
admet-2956	231	5	j. malhotra	PERSON
admet-2956	231	6	r. salgia	PERSON
admet-2956	231	7	s. singhal	PERSON
admet-2956	233	1	13	CARDINAL
admet-2956	233	2	2024	CARDINAL
admet-2956	233	3	45	CARDINAL
admet-2956	234	1	https://doi.org/10.3390/jcm13144189	CARDINAL
admet-2956	234	2	https://doi.org/10.3390/jcm13144189	CARDINAL
admet-2956	234	3	13(5	CARDINAL
admet-2956	234	4	2025	CARDINAL
admet-2956	234	5	2956	CARDINAL
admet-2956	234	6	pd-l1-	GPE
admet-2956	234	7	13	CARDINAL
admet-2956	235	1	3	CARDINAL
admet-2956	235	2	q. huang	PERSON
admet-2956	235	3	y. li	PERSON
admet-2956	235	4	y. huang	PERSON
admet-2956	235	5	j. wu	PERSON
admet-2956	235	6	w. bao	PERSON
admet-2956	235	7	c. xue	PERSON
admet-2956	235	8	s. hu	PERSON
admet-2956	236	1	10 (2025	CARDINAL
admet-2956	236	2	186	CARDINAL
admet-2956	238	1	4	CARDINAL
admet-2956	238	2	m. dawood m. assi	PERSON
admet-2956	239	1	2	CARDINAL
admet-2956	239	2	al-najaf province	GPE
admet-2956	240	1	procedia environmental science engineering	ORG
admet-2956	241	1	11	CARDINAL
admet-2956	241	2	2024	CARDINAL
admet-2956	241	3	465	CARDINAL
admet-2956	242	1	465	CARDINAL
admet-2956	244	1	5	CARDINAL
admet-2956	244	2	h. mamdani	PERSON
admet-2956	244	3	s. matosevic	PERSON
admet-2956	244	4	a. b. khalid	PERSON
admet-2956	244	5	g. durm	PERSON
admet-2956	244	6	s. i. jalal	PERSON
admet-2956	246	1	13	CARDINAL
admet-2956	246	2	2022) 823618	DATE
admet-2956	248	1	6	CARDINAL
admet-2956	248	2	h. e. marei	PERSON
admet-2956	248	3	a. hasan	PERSON
admet-2956	248	4	g. pozzoli	PERSON
admet-2956	248	5	c. cenciarelli	PERSON
admet-2956	250	1	2023	CARDINAL
admet-2956	250	2	64	CARDINAL
admet-2956	252	1	7	CARDINAL
admet-2956	252	2	m. f. sanmamed	PERSON
admet-2956	252	3	l. chen	PERSON
admet-2956	254	1	175	CARDINAL
admet-2956	254	2	2018	DATE
admet-2956	254	3	313	CARDINAL
admet-2956	255	1	8	CARDINAL
admet-2956	255	2	a. abaza	PERSON
admet-2956	255	3	f. idris	PERSON
admet-2956	255	4	h. shaikh	PERSON
admet-2956	255	5	i. vahora	PERSON
admet-2956	255	6	k. moparthi	PERSON
admet-2956	255	7	m. al rushaidi	PERSON
admet-2956	255	8	m. muddam	PERSON
admet-2956	256	1	1	CARDINAL
admet-2956	256	2	1	CARDINAL
admet-2956	257	1	2023	CARDINAL
admet-2956	259	1	https://doi.org/10.7759/cureus.44582	PERSON
admet-2956	260	1	9	CARDINAL
admet-2956	260	2	y. shindo	PERSON
admet-2956	260	3	s. hazama	PERSON
admet-2956	260	4	r. tsunedomi	PERSON
admet-2956	260	5	n. suzuki	PERSON
admet-2956	260	6	h. nagano	PERSON
admet-2956	260	7	11	CARDINAL
admet-2956	260	8	2019) 1223	DATE
admet-2956	262	1	10	CARDINAL
admet-2956	262	2	mejía-guarnizo	PERSON
admet-2956	262	3	p. s. monroy-camacho	PERSON
admet-2956	262	4	a. d. turizo-smith	PERSON
admet-2956	262	5	j. a. rodríguez-garcía	PERSON
admet-2956	264	1	14	CARDINAL
admet-2956	264	2	2023	CARDINAL
admet-2956	264	3	1298571	DATE
admet-2956	265	1	https://doi.org/10.3389/fimmu.2023.1298571	PERSON
admet-2956	266	1	11	CARDINAL
admet-2956	266	2	d. lee	PERSON
admet-2956	266	3	m. cho	PERSON
admet-2956	266	4	e. kim	PERSON
admet-2956	266	5	j. h. cha	PERSON
admet-2956	268	1	32	CARDINAL
admet-2956	268	2	2024	CARDINAL
admet-2956	269	1	12	CARDINAL
admet-2956	269	2	a. mohammed	PERSON
admet-2956	269	3	a. al-gawhari	PERSON
admet-2956	270	1	rosuvastatin calcium-cyclodextrin	PERSON
admet-2956	271	1	11	CARDINAL
admet-2956	271	2	2024	CARDINAL
admet-2956	271	3	117	CARDINAL
admet-2956	273	1	13	CARDINAL
admet-2956	273	2	j. h. cha	PERSON
admet-2956	273	3	l. c. chan	PERSON
admet-2956	273	4	c. w. li	PERSON
admet-2956	273	5	j. l. hsu	PERSON
admet-2956	273	6	m. c. hung	PERSON
admet-2956	275	1	76	CARDINAL
admet-2956	275	2	359	CARDINAL
admet-2956	276	1	14	CARDINAL
admet-2956	276	2	p. g.	PERSON
admet-2956	277	1	abrams r. k. oldham	PERSON
admet-2956	279	1	3	CARDINAL
admet-2956	279	2	1985	DATE
admet-2956	279	3	103	CARDINAL
admet-2956	281	1	15	CARDINAL
admet-2956	281	2	i. maulana	PERSON
admet-2956	281	3	m. prenggono	PERSON
admet-2956	281	4	i. oktavianti	PERSON
admet-2956	281	5	n. kania	PERSON
admet-2956	281	6	r. panghiyangani	PERSON
admet-2956	281	7	n. hasanah	PERSON
admet-2956	283	1	revista latinoamericana	PERSON
admet-2956	284	1	410	CARDINAL
admet-2956	285	1	16	CARDINAL
admet-2956	285	2	w. liu	PERSON
admet-2956	285	3	g. huo	PERSON
admet-2956	285	4	p. chen	PERSON
admet-2956	286	1	first	ORDINAL
admet-2956	287	1	23	CARDINAL
admet-2956	287	2	2023	CARDINAL
admet-2956	289	1	17	CARDINAL
admet-2956	289	2	a. patnaik	PERSON
admet-2956	289	3	s. kang	PERSON
admet-2956	289	4	d. rasco	PERSON
admet-2956	289	5	k. papadopoulos	PERSON
admet-2956	289	6	j. elassaiss-schaap	PERSON
admet-2956	289	7	m. beeram	PERSON
admet-2956	289	8	a. w.	PERSON
admet-2956	291	1	21	CARDINAL
admet-2956	291	2	2015	CARDINAL
admet-2956	291	3	4286-4293	DATE
admet-2956	293	1	18	CARDINAL
admet-2956	293	2	l. pai-scherf	PERSON
admet-2956	293	3	g. blumenthal	PERSON
admet-2956	293	4	h. li	PERSON
admet-2956	293	5	s. subramaniam	PERSON
admet-2956	293	6	p. mishra‐kalyani	PERSON
admet-2956	293	7	k. he	PERSON
admet-2956	293	8	r. pazdur	PERSON
admet-2956	294	1	pembrolizumab	PERSON
admet-2956	294	2	first	ORDINAL
admet-2956	295	1	22	CARDINAL
admet-2956	295	2	2017	CARDINAL
admet-2956	295	3	1392	CARDINAL
admet-2956	296	1	https://doi.org/10.7759/cureus.44582 https://doi.org/10.3390/cancers11091223 https://doi.org/10.3389/fimmu.2023.1298571 https://doi.org/10.1016/j.ymthe.2024.09.026 https://www.procedia-esem.eu/pdf/issues/2024/no1/13_mohammed_24.pdf https://www.procedia-esem.eu/pdf/issues/2024/no1/13_mohammed_24.pdf https://doi.org/10.1016/j.molcel.2019.09.030 https://doi.org/10.1007/978-1-4613-2627-4_5	PERSON
admet-2956	297	1	a. chakramurty et	PERSON
admet-2956	297	2	al. admet	ORG
admet-2956	297	3	13(5	CARDINAL
admet-2956	297	4	2025	CARDINAL
admet-2956	297	5	2956 14	DATE
admet-2956	298	1	19	CARDINAL
admet-2956	299	1	pembrolizumab	PERSON
admet-2956	299	2	keynote-001	PERSON
admet-2956	299	3	two	CARDINAL
admet-2956	300	1	2017	CARDINAL
admet-2956	300	2	1388-1398	DATE
admet-2956	301	1	http://doi.org/10.1093/annonc/mdx076	PRODUCT
admet-2956	301	2	20	CARDINAL
admet-2956	301	3	m. awad	PERSON
admet-2956	301	4	s. gadgeel	PERSON
admet-2956	301	5	h. borghaei	PERSON
admet-2956	301	6	a. patnaik	PERSON
admet-2956	301	7	j. yang	PERSON
admet-2956	301	8	s. powell	PERSON
admet-2956	301	9	c. langer	PERSON
admet-2956	302	1	pemetrexed	PERSON
admet-2956	303	1	2021	CARDINAL
admet-2956	303	2	162	CARDINAL
admet-2956	304	1	21	CARDINAL
admet-2956	304	2	g. mazzaschi	PERSON
admet-2956	304	3	f. barbieri	PERSON
admet-2956	304	4	f. passiglia	PERSON
admet-2956	304	5	f. mazzoni	PERSON
admet-2956	304	6	r. berardi	PERSON
admet-2956	304	7	m. tiseo	PERSON
admet-2956	305	1	first	ORDINAL
admet-2956	306	1	european journal	ORG
admet-2956	306	2	130	CARDINAL
admet-2956	306	3	2020	DATE
admet-2956	306	4	155	CARDINAL
admet-2956	307	1	http://doi.org/10.1016/j.ejca.2020.02.023	ORG
admet-2956	307	2	22	CARDINAL
admet-2956	307	3	m. reck.	PERSON
admet-2956	308	1	pembrolizumab	PERSON
admet-2956	308	2	first	ORDINAL
admet-2956	309	1	10	CARDINAL
admet-2956	309	2	2018	DATE
admet-2956	309	3	93	CARDINAL
admet-2956	311	1	23	CARDINAL
admet-2956	312	1	b. ricciuti	PERSON
admet-2956	312	2	e. jiménez-aguilar	PERSON
admet-2956	312	3	f. hong	PERSON
admet-2956	312	4	z. wei	PERSON
admet-2956	312	5	m. nishino	PERSON
admet-2956	312	6	m. awad	PERSON
admet-2956	313	1	first	ORDINAL
admet-2956	313	2	(≥50%	PERCENT
admet-2956	314	1	8	CARDINAL
admet-2956	314	2	2020	DATE
admet-2956	314	3	78-87	DATE
admet-2956	315	1	24	CARDINAL
admet-2956	315	2	d. ksienski	PERSON
admet-2956	315	3	e. wai	PERSON
admet-2956	315	4	d. alex	PERSON
admet-2956	315	5	n. croteau	PERSON
admet-2956	315	6	a. freeman	PERSON
admet-2956	315	7	a. chan	PERSON
admet-2956	315	8	m. lesperance	PERSON
admet-2956	317	1	10 (2021	CARDINAL
admet-2956	317	2	355	CARDINAL
admet-2956	319	1	25	CARDINAL
admet-2956	319	2	s. ben dori	PERSON
admet-2956	319	3	a. aizic	PERSON
admet-2956	319	4	e. sabo	PERSON
admet-2956	319	5	d. hershkovitz	PERSON
admet-2956	320	1	pd-l1 immunohistochemistry	GPE
admet-2956	321	1	147	CARDINAL
admet-2956	321	2	2020	DATE
admet-2956	321	3	91	CARDINAL
admet-2956	322	1	26	CARDINAL
admet-2956	322	2	saito s. horiuchi	PERSON
admet-2956	322	3	h. morooka	PERSON
admet-2956	322	4	t. ibi	PERSON
admet-2956	322	5	n. takahashi	PERSON
admet-2956	322	6	t. ikeya	PERSON
admet-2956	322	7	e. hoshi	PERSON
admet-2956	324	1	11	CARDINAL
admet-2956	324	2	2019	CARDINAL
admet-2956	324	3	4982-4991	DATE
admet-2956	325	1	http://doi.org/10.21037/jtd.2019.12.24	DATE
admet-2956	326	1	27	CARDINAL
admet-2956	326	2	e. sajjadi	PERSON
admet-2956	326	3	k. venetis	PERSON
admet-2956	326	4	c. scatena	PERSON
admet-2956	326	5	n. fusco	PERSON
admet-2956	328	1	ecancermedicalscience	PERSON
admet-2956	328	2	14	DATE
admet-2956	328	3	2020	DATE
admet-2956	328	4	78-89	DATE
admet-2956	330	1	28	CARDINAL
admet-2956	330	2	n. guibert	PERSON
admet-2956	330	3	j. milia	PERSON
admet-2956	330	4	j. mazieres	PERSON
admet-2956	334	1	29	CARDINAL
admet-2956	334	2	c. stratton	PERSON
admet-2956	334	3	f. thomson	PERSON
admet-2956	334	4	m. baxter	PERSON
admet-2956	334	5	h. cagney	PERSON
admet-2956	334	6	i. phillips	PERSON
admet-2956	335	1	first	ORDINAL
admet-2956	336	1	7	CARDINAL
admet-2956	336	2	2022	CARDINAL
admet-2956	336	3	100445	DATE
admet-2956	337	1	http://doi.org/10.1016/j.esmoop.2022.100445	ORG
admet-2956	338	1	30	CARDINAL
admet-2956	338	2	k. l. ayers	PERSON
admet-2956	338	3	m. ma	PERSON
admet-2956	338	4	g. debussche	PERSON
admet-2956	338	5	d. corrigan	PERSON
admet-2956	338	6	j. mccafferty	PERSON
admet-2956	338	7	k. lee	PERSON
admet-2956	338	8	s. d. li	PERSON
admet-2956	340	1	21	CARDINAL
admet-2956	340	2	2021	CARDINAL
admet-2956	340	3	441	CARDINAL
admet-2956	341	1	31	CARDINAL
admet-2956	341	2	y. zhou	PERSON
admet-2956	341	3	z. lin	PERSON
admet-2956	341	4	x. zhang	PERSON
admet-2956	341	5	c. chen	PERSON
admet-2956	341	6	h. zhao	PERSON
admet-2956	341	7	s. hong	PERSON
admet-2956	341	8	l. zhang	PERSON
admet-2956	342	1	first	ORDINAL
admet-2956	342	2	pembrolizumab	PERSON
admet-2956	342	3	pembrolizumab	PERSON
admet-2956	343	1	7	CARDINAL
admet-2956	343	2	2019	CARDINAL
admet-2956	343	3	120	CARDINAL
admet-2956	345	1	32	CARDINAL
admet-2956	345	2	e. fountzilas	PERSON
admet-2956	345	3	s. lampaki	PERSON
admet-2956	345	4	g. koliou	PERSON
admet-2956	345	5	a. koumarianou	PERSON
admet-2956	345	6	s. levva	PERSON
admet-2956	345	7	a. vagionas	PERSON
admet-2956	345	8	d. bafaloukos	PERSON
admet-2956	346	1	hellenic	NORP
admet-2956	347	1	71	CARDINAL
admet-2956	347	2	2022	CARDINAL
admet-2956	347	3	327	CARDINAL
admet-2956	349	1	33	CARDINAL
admet-2956	349	2	m. bieńkowski	PERSON
admet-2956	349	3	m. braun	PERSON
admet-2956	349	4	s. popat	PERSON
admet-2956	349	5	r. dziadziuszko	PERSON
admet-2956	350	1	158	CARDINAL
admet-2956	350	2	2021	CARDINAL
admet-2956	350	3	97	CARDINAL
admet-2956	351	1	http://doi.org/10.1093/annonc/mdx076 http://doi.org/10.1016/j.jtho.2020.09.015 http://doi.org/10.1016/j.ejca.2020.02.023	PERSON
admet-2956	351	2	http://doi.org/10.21037/jtd.2019.12.24 http://doi.org/10.3332/ecancer.2020.1150	DATE
admet-2956	351	3	13(5	CARDINAL
admet-2956	351	4	2025	CARDINAL
admet-2956	351	5	2956	CARDINAL
admet-2956	351	6	pd-l1-	GPE
admet-2956	351	7	15	CARDINAL
admet-2956	351	8	34	CARDINAL
admet-2956	351	9	c. j. d. wallis	PERSON
admet-2956	351	10	m. butaney	PERSON
admet-2956	351	11	r. satkunasivam	PERSON
admet-2956	351	12	s. freedland	PERSON
admet-2956	351	13	s. patel	PERSON
admet-2956	351	14	o. hamid	PERSON
admet-2956	351	15	z. klaassen	PERSON
admet-2956	353	1	jama oncology 5	PERSON
admet-2956	353	2	2019	CARDINAL
admet-2956	353	3	529	CARDINAL
admet-2956	354	1	35	CARDINAL
admet-2956	354	2	f. yang	PERSON
admet-2956	354	3	s. markovic	PERSON
admet-2956	354	4	j. molina	PERSON
admet-2956	354	5	t. halfdanarson	PERSON
admet-2956	354	6	l. pagliaro	PERSON
admet-2956	354	7	a. chintakuntlawar y. wang	PERSON
admet-2956	355	1	eastern cooperative oncology group	ORG
admet-2956	356	1	3	CARDINAL
admet-2956	357	1	36	CARDINAL
admet-2956	357	2	schwartzberg	PERSON
admet-2956	357	3	b. korytowsky	PERSON
admet-2956	357	4	j. penrod	PERSON
admet-2956	357	5	y. zhang	PERSON
admet-2956	357	6	t. le	GPE
admet-2956	357	7	c. batenchuk	PERSON
admet-2956	357	8	l. krug	PERSON
admet-2956	359	1	20	CARDINAL
admet-2956	359	2	287	CARDINAL
admet-2956	360	1	37	CARDINAL
admet-2956	360	2	a. f. kaizal	PERSON
admet-2956	360	3	j. algburi	PERSON
admet-2956	360	4	m. al-haidarey	PERSON
admet-2956	362	1	11	CARDINAL
admet-2956	362	2	2024	CARDINAL
admet-2956	362	3	83-89	DATE
admet-2956	364	1	38	CARDINAL
admet-2956	364	2	k. amrane	PERSON
admet-2956	365	1	first	ORDINAL
admet-2956	365	2	pd-l1 ≥50%	GPE
admet-2956	366	1	9	CARDINAL
admet-2956	368	1	39	CARDINAL
admet-2956	368	2	g. wagner	PERSON
admet-2956	368	3	h. k. stollenwerk	PERSON
admet-2956	368	4	i. klerings	PERSON
admet-2956	368	5	m. pecherstorfer	PERSON
admet-2956	368	6	g. gartlehner	PERSON
admet-2956	368	7	j. singer	PERSON
admet-2956	370	1	9	CARDINAL
admet-2956	370	2	2020	DATE
admet-2956	370	3	45	CARDINAL
admet-2956	372	1	40	CARDINAL
admet-2956	372	2	m. liu	PERSON
admet-2956	372	3	j. miao	PERSON
admet-2956	372	4	y. liao	PERSON
admet-2956	372	5	d. cai	PERSON
admet-2956	373	1	anti-pd-l1	NORP
admet-2956	374	1	9 (2018) 12001206.	PERCENT
admet-2956	376	1	41	CARDINAL
admet-2956	376	2	k. nesline	PERSON
admet-2956	376	3	t. knight	PERSON
admet-2956	376	4	s. colman	PERSON
admet-2956	376	5	k. patel	PERSON
admet-2956	378	1	42	DATE
admet-2956	378	2	2020	DATE
admet-2956	379	1	42	CARDINAL
admet-2956	379	2	x. ma	PERSON
admet-2956	379	3	l. bellomo	PERSON
admet-2956	379	4	k. magee	PERSON
admet-2956	379	5	c. bennette	PERSON
admet-2956	379	6	m. samant	PERSON
admet-2956	379	7	a. bourla	PERSON
admet-2956	380	1	38	CARDINAL
admet-2956	380	2	2021	CARDINAL
admet-2956	380	3	1843-1859	DATE
admet-2956	382	1	43	CARDINAL
admet-2956	382	2	l. paz-ares	PERSON
admet-2956	382	3	a. luft	PERSON
admet-2956	382	4	d. vicente	GPE
admet-2956	382	5	a. tafreshi	PERSON
admet-2956	382	6	m. gümüş	PERSON
admet-2956	382	7	j. mazières	PERSON
admet-2956	382	8	d. kowalski	PERSON
admet-2956	383	1	pembrolizumab	PERSON
admet-2956	384	1	new england journal of medicine	ORG
admet-2956	384	2	379	CARDINAL
admet-2956	384	3	2018	DATE
admet-2956	384	4	2040	CARDINAL
admet-2956	385	1	44	CARDINAL
admet-2956	385	2	r. herbst	PERSON
admet-2956	385	3	d. kim	PERSON
admet-2956	385	4	e. felip	PERSON
admet-2956	385	5	j. pérez-gracia	PERSON
admet-2956	385	6	j. han	PERSON
admet-2956	385	7	e. garon	PERSON
admet-2956	385	8	pembrolizumab	PERSON
admet-2956	385	9	keynote-010	PERSON
admet-2956	386	1	387	CARDINAL
admet-2956	386	2	2016	CARDINAL
admet-2956	386	3	1540-1550	DATE
admet-2956	388	1	45	CARDINAL
admet-2956	388	2	c. langer	PERSON
admet-2956	388	3	s. gadgeel	PERSON
admet-2956	388	4	h. borghaei	PERSON
admet-2956	388	5	a. patnaik	PERSON
admet-2956	388	6	s. powell	PERSON
admet-2956	388	7	l. gandhi	PERSON
admet-2956	389	1	carboplatin	PERSON
admet-2956	389	2	2	CARDINAL
admet-2956	390	1	lancet oncology 17	ORG
admet-2956	390	2	2016	CARDINAL
admet-2956	390	3	1497-1508	DATE
admet-2956	392	1	46	CARDINAL
admet-2956	392	2	y. wu	PERSON
admet-2956	392	3	i. kudaba	PERSON
admet-2956	392	4	d. kowalski	PERSON
admet-2956	392	5	b. cho	PERSON
admet-2956	392	6	g. martinengo	PERSON
admet-2956	393	1	pembrolizumab	PERSON
admet-2956	393	2	keynote-042	ORG
admet-2956	393	3	3	CARDINAL
admet-2956	394	1	393	CARDINAL
admet-2956	394	2	2019	CARDINAL
admet-2956	394	3	1819-1830	DATE
admet-2956	396	1	47	CARDINAL
admet-2956	396	2	s. ren	PERSON
admet-2956	396	3	j. feng	PERSON
admet-2956	396	4	s. ma	PERSON
admet-2956	396	5	h. chen	PERSON
admet-2956	396	6	z. ma	PERSON
admet-2956	396	7	c. huang	PERSON
admet-2956	396	8	c. zhou	PERSON
admet-2956	397	1	keynote‐033	PERSON
admet-2956	397	2	3	CARDINAL
admet-2956	398	1	153	CARDINAL
admet-2956	398	2	2023	CARDINAL
admet-2956	398	3	623	CARDINAL
admet-2956	399	1	48	CARDINAL
admet-2956	399	2	l. gandhi	PERSON
admet-2956	399	3	d. rodgríguez-abreu	PERSON
admet-2956	399	4	s. gadgeel	PERSON
admet-2956	399	5	e. esteban	PERSON
admet-2956	399	6	e. felip	PERSON
admet-2956	399	7	m. garassino	PERSON
admet-2956	400	1	3	CARDINAL
admet-2956	400	2	pembrolizumab	ORG
admet-2956	402	1	a. chakramurty et al	PERSON
admet-2956	402	2	13(5	CARDINAL
admet-2956	402	3	2025	CARDINAL
admet-2956	402	4	2956 16	CARDINAL
admet-2956	402	5	first	ORDINAL
admet-2956	403	1	2018	DATE
admet-2956	404	1	49	CARDINAL
admet-2956	404	2	j. r. brahmer	PERSON
admet-2956	405	1	8937	DATE
admet-2956	406	1	european journal	ORG
admet-2956	406	2	199	CARDINAL
admet-2956	406	3	2024) 113530	DATE
admet-2956	407	1	http://doi.org/10.1016/j.ejca.2024.113530	ORG
admet-2956	408	1	50	CARDINAL
admet-2956	410	1	2020	DATE
admet-2956	410	2	1265	CARDINAL
admet-2956	411	1	51	CARDINAL
admet-2956	411	2	b. zhao	PERSON
admet-2956	413	1	british medical	ORG
admet-2956	413	2	362	CARDINAL
admet-2956	413	3	2018	DATE
admet-2956	413	4	43	CARDINAL
admet-2956	414	1	52	CARDINAL
admet-2956	414	2	g. bronte	PERSON
admet-2956	414	3	v. bazan	PERSON
admet-2956	414	4	c. natoli	PERSON
admet-2956	414	5	s. rizzo	PERSON
admet-2956	414	6	a. galvano	PERSON
admet-2956	414	7	a. russo pd-l1	PERSON
admet-2956	415	1	2016	CARDINAL
admet-2956	415	2	19738-19747	DATE
admet-2956	416	1	53	CARDINAL
admet-2956	416	2	r. ferrara	PERSON
admet-2956	416	3	l. mezquita	PERSON
admet-2956	416	4	e. auclin	PERSON
admet-2956	416	5	n. chaput	PERSON
admet-2956	416	6	b. besse	PERSON
admet-2956	417	1	immunosenescence	ORG
admet-2956	418	1	60	CARDINAL
admet-2956	418	2	2017	CARDINAL
admet-2956	418	3	60	CARDINAL
admet-2956	419	1	54	CARDINAL
admet-2956	419	2	c. wang	PERSON
admet-2956	421	1	8	CARDINAL
admet-2956	421	2	4023-4031	DATE
admet-2956	423	1	55	CARDINAL
admet-2956	423	2	s. popat	PERSON
admet-2956	423	3	k. kerr	PERSON
admet-2956	423	4	s. novello	PERSON
admet-2956	423	5	e. smit	PERSON
admet-2956	423	6	c. faivre-finn	PERSON
admet-2956	424	1	29	CARDINAL
admet-2956	424	2	2018	DATE
admet-2956	425	1	http://doi.org/10.1093/annonc/mdy275	ORG
admet-2956	426	1	56	CARDINAL
admet-2956	426	2	j. mclaughlin	PERSON
admet-2956	428	1	2016	CARDINAL
admet-2956	428	2	46	CARDINAL
admet-2956	429	1	57	CARDINAL
admet-2956	429	2	j. yearley	PERSON
admet-2956	429	3	i. shintaku	PERSON
admet-2956	429	4	e. taylor	PERSON
admet-2956	429	5	l. robert	PERSON
admet-2956	429	6	a. ribas	PERSON
admet-2956	431	1	2014	DATE
admet-2956	431	2	568	CARDINAL
admet-2956	433	1	58	CARDINAL
admet-2956	433	2	k. ninomiya	PERSON
admet-2956	433	3	i. oze	PERSON
admet-2956	433	4	y. kato	PERSON
admet-2956	433	5	t. kubo	PERSON
admet-2956	433	6	e. ichihara	PERSON
admet-2956	433	7	k. rai	PERSON
admet-2956	433	8	k. hotta	PERSON
admet-2956	435	1	59	DATE
admet-2956	435	2	2020	DATE
admet-2956	435	3	249	CARDINAL
admet-2956	437	1	59	CARDINAL
admet-2956	437	2	e. muchnik	PERSON
admet-2956	437	3	k. loh	PERSON
admet-2956	437	4	m. strawderman	PERSON
admet-2956	437	5	a. magnuson	PERSON
admet-2956	437	6	s. mohile	PERSON
admet-2956	437	7	v. estrah	GPE
admet-2956	437	8	r. maggiore	PERSON
admet-2956	439	1	the american geriatrics society 67 (	ORG
admet-2956	439	2	2019	CARDINAL
admet-2956	439	3	905	CARDINAL
admet-2956	441	1	60	CARDINAL
admet-2956	441	2	s. l. klein	PERSON
admet-2956	441	3	k. l. flanagan	PERSON
admet-2956	443	1	16	CARDINAL
admet-2956	443	2	2016	CARDINAL
admet-2956	443	3	626	CARDINAL
admet-2956	445	1	61	CARDINAL
admet-2956	445	2	k. a. marrone	PERSON
admet-2956	445	3	w. ying	PERSON
admet-2956	445	4	j. naidoo	PERSON
admet-2956	446	1	100	CARDINAL
admet-2956	446	2	2016	CARDINAL
admet-2956	446	3	242	CARDINAL
admet-2956	447	1	http://doi.org/10.1002/cpt.394	PERSON
admet-2956	448	1	62	CARDINAL
admet-2956	448	2	r. jin	PERSON
admet-2956	449	1	c. liu	PERSON
admet-2956	449	2	s. zheng	PERSON
admet-2956	449	3	x. wang	PERSON
admet-2956	449	4	x. feng	PERSON
admet-2956	449	5	h. li	PERSON
admet-2956	450	1	anti-pd-1	NORP
admet-2956	450	2	east asian	NORP
admet-2956	451	1	17	CARDINAL
admet-2956	451	2	2020	DATE
admet-2956	451	3	768	CARDINAL
admet-2956	453	1	63	CARDINAL
admet-2956	453	2	c. zhang	PERSON
admet-2956	453	3	j. zhang	PERSON
admet-2956	453	4	j. tan	PERSON
admet-2956	453	5	p. tian	PERSON
admet-2956	453	6	w. li	PERSON
admet-2956	454	1	12	CARDINAL
admet-2956	454	2	2022	CARDINAL
admet-2956	454	3	198	CARDINAL
admet-2956	455	1	64	CARDINAL
admet-2956	455	2	f. a. van delft	PERSON
admet-2956	457	1	8	CARDINAL
admet-2956	457	2	2022	CARDINAL
admet-2956	458	1	65	CARDINAL
admet-2956	458	2	s. m. batool,	PERSON
admet-2956	458	3	a. yekula	PERSON
admet-2956	458	4	khanna	PERSON
admet-2956	458	5	t. hsia	PERSON
admet-2956	458	6	a. gamblin	PERSON
admet-2956	458	7	e. ekanayake	PERSON
admet-2956	460	1	4	CARDINAL
admet-2956	460	2	2023) 101198	DATE
admet-2956	461	1	http://doi.org/10.1016/j.ctrv.2017.08.003	ORG
admet-2956	461	2	http://doi.org/10.1002/cpt.394	PERSON
admet-2956	461	3	13(5	CARDINAL
admet-2956	461	4	2025	CARDINAL
admet-2956	461	5	2956	CARDINAL
admet-2956	461	6	pd-l1-	GPE
admet-2956	461	7	17	CARDINAL
admet-2956	461	8	66	CARDINAL
admet-2956	461	9	m. qiao	PERSON
admet-2956	461	10	t. jiang	GPE
admet-2956	461	11	s. ren	PERSON
admet-2956	461	12	c. zhou	PERSON
admet-2956	463	1	19	CARDINAL
admet-2956	463	2	2018	DATE
admet-2956	463	3	1	CARDINAL
admet-2956	465	1	67	CARDINAL
admet-2956	465	2	f. conforti	PERSON
admet-2956	467	1	the national cancer institute	ORG
admet-2956	467	2	111	CARDINAL
admet-2956	467	3	2019	CARDINAL
admet-2956	467	4	772	CARDINAL
admet-2956	469	1	68	CARDINAL
admet-2956	469	2	s. chandwani	PERSON
admet-2956	469	3	x. chen	PERSON
admet-2956	469	4	m. catherine	PERSON
admet-2956	469	5	t. burke	PERSON
admet-2956	470	1	first	ORDINAL
admet-2956	471	1	11	CARDINAL
admet-2956	471	2	889-901	CARDINAL
admet-2956	472	1	69	CARDINAL
admet-2956	472	2	s. liang	PERSON
admet-2956	472	3	h. wang	PERSON
admet-2956	472	4	h. tian	PERSON
admet-2956	472	5	z. xu	PERSON
admet-2956	472	6	m. wu	PERSON
admet-2956	472	7	d. hua	PERSON
admet-2956	472	8	c. li	PERSON
admet-2956	474	1	14	CARDINAL
admet-2956	474	2	2023	CARDINAL
admet-2956	474	3	1249980	DATE
admet-2956	476	1	70	CARDINAL
admet-2956	476	2	a. prelaj	PERSON
admet-2956	476	3	e. galli	PERSON
admet-2956	476	4	v. miskovic	PERSON
admet-2956	476	5	m. pesenti	PERSON
admet-2956	476	6	g. viscardi	PERSON
admet-2956	476	7	b. pedica	PERSON
admet-2956	476	8	a. pedrocchi	PERSON
admet-2956	478	1	2023) 1078822	DATE
admet-2956	479	1	2025	CARDINAL
admet-2956	479	2	iapc	ORG
admet-2956	479	3	zagreb	GPE
admet-2956	479	4	croatia	GPE
admet-2956	480	1	http://creativecommons.org/licenses/by/3.0/	ORG
admet-2956	481	1	http://creativecommons.org/licenses/by/3.0/	ORG